tiprankstipranks
MicroTech Medical (Hangzhou) Co., Ltd. Class H (HK:2235)
:2235
Hong Kong Market
2235
MicroTech Medical (Hangzhou) Co., Ltd. Class H
RESEARCH TOOLSreports
Want to see HK:2235 full AI Analyst Report?

MicroTech Medical (Hangzhou) Co., Ltd. Class H (2235) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

2235 Analyst Ratings

Moderate Buy
3Ratings
Moderate Buy
2 Buy
1 Hold
0 Sell
Based on 3 analysts giving stock ratings to
MicroTech
Medical (Hangzhou) Co., Ltd. Class H
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

2235 Stock 12 Month Forecast

Average Price Target

HK$11.63
▲(63.85% Upside)
Based on 3 Wall Street analysts offering 12 month price targets for MicroTech Medical (Hangzhou) Co., Ltd. Class H in the last 3 months. The average price target is HK$11.63 with a high forecast of HK$14.00 and a low forecast of HK$8.90. The average price target represents a 63.85% change from the last price of HK$7.10.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"4":"HK$4","15":"HK$15","6.75":"HK$6.75","9.5":"HK$9.5","12.25":"HK$12.25"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":14,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">HK$14.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":11.633333333333333,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">HK$11.63</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":8.9,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">HK$8.90</span>\n  </div></div>","useHTML":true}}],"tickPositions":[4,6.75,9.5,12.25,15],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2025","6":"Jan<br/>2026","9":"Apr<br/>2026","12":"Jul<br/>2026","25":"Jul<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,7.1,7.63076923076923,8.161538461538461,8.692307692307692,9.223076923076922,9.753846153846153,10.284615384615385,10.815384615384616,11.346153846153847,11.876923076923077,12.407692307692308,12.938461538461539,13.46923076923077,{"y":14,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,7.1,7.448717948717948,7.797435897435897,8.146153846153846,8.494871794871795,8.843589743589742,9.192307692307692,9.54102564102564,9.889743589743588,10.238461538461538,10.587179487179487,10.935897435897434,11.284615384615384,{"y":11.633333333333333,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,7.1,7.2384615384615385,7.3769230769230765,7.515384615384615,7.653846153846153,7.792307692307692,7.930769230769231,8.069230769230769,8.207692307692309,8.346153846153847,8.484615384615385,8.623076923076923,8.761538461538462,{"y":8.9,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":5.92,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.71,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8.64,"date":1756684800000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":8.07,"date":1759276800000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":6.68,"date":1761955200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":6.43,"date":1764547200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":7.93,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.64,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.59,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.38,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.99,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.4,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.1,"date":1782864000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price TargetHK$14.00Average Price TargetHK$11.63Lowest Price TargetHK$8.90
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Citic Securities Analyst forecast on HK:2235
Unknown Analyst
Citic Securities
Not Ranked
Citic Securities
HK$12
Buy
69.01%
Upside
Reiterated
04/29/26
Citic Securities Keeps Their Buy Rating on MicroTech Medical (Hangzhou) Co., Ltd. Class H (2235)
Goldman Sachs Analyst forecast on HK:2235
Chris Pan
Goldman Sachs
Goldman Sachs
HK$8.9
Hold
25.35%
Upside
Upgraded
04/26/26
Goldman Sachs upgrades MicroTech Medical (Hangzhou) Co., Ltd. Class H (2235) to a Hold
Huachuang Securities Analyst forecast on HK:2235
Unknown Analyst
Huachuang Securities
Not Ranked
Huachuang Securities
HK$14
Buy
97.18%
Upside
Reiterated
04/15/26
Huachuang Securities Remains a Buy on MicroTech Medical (Hangzhou) Co., Ltd. Class H (2235)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Citic Securities Analyst forecast on HK:2235
Unknown Analyst
Citic Securities
Not Ranked
Citic Securities
HK$12
Buy
69.01%
Upside
Reiterated
04/29/26
Citic Securities Keeps Their Buy Rating on MicroTech Medical (Hangzhou) Co., Ltd. Class H (2235)
Goldman Sachs Analyst forecast on HK:2235
Chris Pan
Goldman Sachs
Goldman Sachs
HK$8.9
Hold
25.35%
Upside
Upgraded
04/26/26
Goldman Sachs upgrades MicroTech Medical (Hangzhou) Co., Ltd. Class H (2235) to a Hold
Huachuang Securities Analyst forecast on HK:2235
Unknown Analyst
Huachuang Securities
Not Ranked
Huachuang Securities
HK$14
Buy
97.18%
Upside
Reiterated
04/15/26
Huachuang Securities Remains a Buy on MicroTech Medical (Hangzhou) Co., Ltd. Class H (2235)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
TRAXFirst Tracks Biotherapeutics Inc
EVMNEvommune, Inc.
MPLTMapLight Therapeutics, Inc.
MAZEMaze Therapeutics, Inc.
AAPGAscentage Pharma Group International Unsponsored ADR
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering MicroTech Medical (Hangzhou) Co., Ltd. Class H

3 Months
Google Health Care HKTipRanks - Google
Success Rate
0/1 ratings generated profit
0%
Average Return
-6.70%
Copying Google Health Care HK's trades and holding each position for 3 Months would result in 0.00% of your transactions generating a profit, with an average return of -6.70% per trade.
1 Year
Google Health Care HKTipRanks - Google
Success Rate
0/1 ratings generated profit
0%
Average Return
-6.70%
Copying Google Health Care HK's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -6.70% per trade.
2 Years
Google Health Care HKTipRanks - Google
Success Rate
0/1 ratings generated profit
0%
Average Return
-6.70%
Copying Google Health Care HK's trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -6.70% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

2235 Analyst Recommendation Trends

Rating
Mar 26
Apr 26
May 26
Jun 26
Jul 26
Strong Buy
2
3
3
2
0
Buy
0
0
0
0
0
Hold
0
1
1
1
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
2
4
4
3
0
In the current month, 2235 has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 2235 average Analyst price target in the past 3 months is 11.63.
Each month's total comprises the sum of three months' worth of ratings.

2235 Financial Forecast

2235 Earnings Forecast

Next quarter’s earnings estimate for 2235 is HK$0.09 with a range of HK$0.09 to HK$0.09. The previous quarter’s EPS was HK$0.12. 2235 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year 2235 has Performed in-line its overall industry.
Next quarter’s earnings estimate for 2235 is HK$0.09 with a range of HK$0.09 to HK$0.09. The previous quarter’s EPS was HK$0.12. 2235 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year 2235 has Performed in-line its overall industry.

2235 Sales Forecast

Next quarter’s sales forecast for 2235 is HK$431.64M with a range of HK$431.64M to HK$431.64M. The previous quarter’s sales results were HK$454.17M. 2235 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year 2235 has Performed in-line its overall industry.
Next quarter’s sales forecast for 2235 is HK$431.64M with a range of HK$431.64M to HK$431.64M. The previous quarter’s sales results were HK$454.17M. 2235 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year 2235 has Performed in-line its overall industry.

2235 Stock Forecast FAQ

What is HK:2235’s average 12-month price target, according to analysts?
Based on analyst ratings, MicroTech Medical (Hangzhou) Co., Ltd. Class H’s 12-month average price target is 11.63.
    What is HK:2235’s upside potential, based on the analysts’ average price target?
    MicroTech Medical (Hangzhou) Co., Ltd. Class H has 63.85% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is MicroTech Medical (Hangzhou) Co., Ltd. Class H a Buy, Sell or Hold?
          MicroTech Medical (Hangzhou) Co., Ltd. Class H has a consensus rating of Moderate Buy, which is based on 2 buy ratings, 1 hold ratings and 0 sell ratings.
            What is MicroTech Medical (Hangzhou) Co., Ltd. Class H’s share price target?
            The average share price target for MicroTech Medical (Hangzhou) Co., Ltd. Class H is 11.63. This is based on 3 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is HK$14.00 ,and the lowest forecast is HK$8.90. The average share price target represents 63.85% Increase from the current price of HK$7.1.
              What do analysts say about MicroTech Medical (Hangzhou) Co., Ltd. Class H?
              MicroTech Medical (Hangzhou) Co., Ltd. Class H’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 3 Wall Streets Analysts.
                How can I buy shares of MicroTech Medical (Hangzhou) Co., Ltd. Class H?
                To buy shares of HK:2235, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.